Molecular Analysis of Influenza A (A/H3N2) Viruses Indicates Antigenic Drift in the Receptor Binding Domain and Potential Vaccine Mismatch Among Strains in Riyadh, Saudi Arabia, 2024–2025 - Report - MDSpire

Molecular Analysis of Influenza A (A/H3N2) Viruses Indicates Antigenic Drift in the Receptor Binding Domain and Potential Vaccine Mismatch Among Strains in Riyadh, Saudi Arabia, 2024–2025

  • By

  • Shatha Ata Abdulgader

  • Ibrahim M. Aziz

  • Abdulhadi M. Abdulwahed

  • Mohamed A. Farrag

  • Reem M. Aljowaie

  • Abdulaziz M. Almuqrin

  • Noorah A. Alkubaisi

  • Fahad N. Almajhdi

  • February 19, 2026

  • 0 min

Share

Clinical Report: Molecular Analysis of Influenza A (A/H3N2) Viruses in Riyadh

Overview

This study reveals significant antigenic drift in A/H3N2 viruses in Riyadh, Saudi Arabia, during the 2024–2025 season, indicating potential vaccine mismatch. The findings underscore the necessity for ongoing surveillance and timely vaccine reformulation to enhance public health responses.

Background

Influenza A viruses are a leading cause of respiratory illness globally, with A/H3N2 subtypes exhibiting notable antigenic drift. This drift complicates vaccine effectiveness, necessitating continuous monitoring to inform vaccine updates. The unique epidemiological context of Saudi Arabia, characterized by mass gatherings and high population mobility, further emphasizes the importance of understanding local viral dynamics.

Data Highlights

No numerical data available in the source material.

Key Findings

  • Antigenic drift was observed in the receptor binding domain of A/H3N2 viruses.
  • Potential vaccine mismatch was identified among circulating strains in Riyadh.
  • Prevalence of A/H3N2 viruses was assessed through molecular characterization of isolates.
  • Amino acid substitutions were noted within key antigenic sites, impacting vaccine strain compatibility.
  • N-glycosylation patterns were evaluated to understand their role in antigenicity.

Clinical Implications

Healthcare professionals should remain vigilant regarding the evolving nature of influenza viruses, particularly A/H3N2. Continuous genetic and antigenic monitoring is essential for timely vaccine updates, which can significantly impact public health outcomes during influenza seasons.

Conclusion

The findings from this study highlight the critical need for ongoing surveillance of A/H3N2 viruses in Riyadh to inform vaccination strategies and mitigate the impact of influenza epidemics.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. CDC, MMWR, 2025 -- Interim Estimates of 2025–26 Seasonal Influenza Vaccine Effectiveness
  6. CDC, MMWR, 2025 -- Prevention and Control of Seasonal Influenza with Vaccines
  7. CDC, MMWR, 2025 -- Interim Estimates of 2025–26 Seasonal Influenza Vaccine Effectiveness in California
  8. Interim Estimates of 2025–26 Seasonal Influenza Vaccine Effectiveness — United States, September 2025–February 2026 | MMWR
  9. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2025–26 Influenza Season | MMWR
  10. Interim Estimates of 2025–26 Seasonal Influenza Vaccine Effectiveness — California, October 2025–January 2026 | MMWR

Original Source(s)

Related Content